Novel Derivatives of 1,3-Dimethyl-5-methylenebarbituric Acid
Letters in Organic Chemistry, 2009, Vol. 6, No. 8
671
solution produces 7 which was characterized by NMR, MS
and elemental analysis. The DEPT-NMR analysis of 7
showed that protonation occurred at each C5 atom of the
barbiturate rings rather than at oxygen atoms (Scheme 1)
leading to a keto-form tautomer which was reported formerly
[13]. Other nucleophiles including iodide anion, phenol and
thioanisol failed to substitute the pyridinium fragment in 2
even under reflux.
(C6H6N2O3)], 323 (9) [M+]. Anal. Calcd. for C13H15N4O6Na:
C, 45.1; H, 4.4; N, 16.2. Found: C, 44.7; H, 4.8; N, 16.0%.
1,3-dimethyl-5-{[{2-[[(1-methyl-6-oxido-2,4-dioxo-1,2,3,4-
tetrahydro-5-pyrimidinyl) methyl](diphenyl)phosphonio]
ethyl}(diphenyl)phosphonio]methyl}-2,6-dioxo-1,2,3,6-tetr-
ahydro-4-pyrimidinolate (5)
3.0 mmol (0.74 g) of 2 was dissolved in 15.0 mL of
CH2Cl2, and then 1.5 mmol (0.59 g) of 1,2-
bis(diphenylphosphino)ethane was added in one portion to
the solution which was stirred at r.t overnight. The
precipitate was filtered off, washed with CH2Cl2 and dried
under vacuum.
EXPERIMENTAL
Materials and Instruments
All experiments have been performed in purified solvents
under argon. 1,3-Dimethylbarbituric acid (B), formaldehyde
solution (37%), sodium cyanide, sodium hydroxide, 1,2-
bis(diphenylphosphino)ethane, and sodium sulfide were
purchased from Aldrich and used without further
purification. Nuclear magnetic resonance (NMR) spectra
were acquired by a Bruker DRX 400 NMR spectrometer
with tetramethylsilane (1H, 13C) and 85% H3PO4 (31P) as
external standards. The FAB-mass spectra were obtained on
a Finnigan TQS 70 by 70 eV in 3-nitrobenzylalcohol (NBA)-
matrix at 30°C. Elemental analyses were determined by
Carlo Erba Company, model 1106. Melting points were
obtained by the device from Büchi, model 510.
Yield: 80%; m.p. 253-256 °C (decomp.); 1H NMR
(400.13 MHz, CDCl3): 3.01 (m, 4H, P-(CH2)2-P), 3.09 (s,
12H, 1,3B-Me); 3.99 (d, 4H, B-CH2-P, J= 7.5 Hz); 7.58-7.77
(m, 20 H, Ph) ppm. 13C NMR (100.62 MHz, CDCl3): 15.9
(d, B-CH2-P, Jpc = 47.9 Hz); 20.7 (d, CH2-P, Jpc = 47.7 Hz);
27.6 (1,3B-Me); 72.7 (C5 ); 119.5 (d, Carom, Jpc = 79.8 Hz),
B
130.0 (Cm), 132.9 (Co), 134.6 (Cp); 153.1 (C2 ); 163.8 (C4,6
)
B
B
ppm. 31P NMR (161.98 MHz, CDCl3): 23.9 ppm. MS (FAB):
m/z (%)
=
399 (100) [Ph4P2C2H4], 567 (49) [M+-
(C7H8N2O3)], 734 (3) [M+]. Anal. Calcd. for C40H40N4O6P2:
C, 65.4; H, 5.5; N, 7.6. Found: C, 65.0; H, 5.9; N, 7.8%.
Disodium 5-[(5-{[({5-[(1,3-dimethyl-6-oxido-2,4-dioxo-1,2,
3,4-tetrahydro-5-pyrimidinyl) methyl]-1,3-dimethyl-2,4,6-
trioxohexahydro-5-pyrimidinyl}methyl) sulfanyl]methyl}-
1,3-dimethyl-2,4,6-trioxohexahydro-5-pyrimidinyl)methyl]-
1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-4-pyrimidinolate
(6)
Sodium 5-(cyanomethyl)-1,3-dimethyl-2,6-dioxo-1,2,3,6-
tetrahydro-4-pyrimidinolate (3)
2.5 mmol (0.62 g) of 2 was dissolved in 20.0 mL of H2O,
and then 2.3 mmol (0.11 g) of NaCN was added in one
portion to the aqueous solution which was stirred at r.t
overnight. The solvent was removed under vacuum; the
residue was then washed with CHCl3, filtered and dried
under vacuum.
To a suspended solution of 3.0 mmol (0.74 g) of 2 in 25.0
mL of THF, 12.0 mmol (0.94 g) of sodium sulfide was added
in one portion to the solution which was stirred at r.t for 72
h. The solvent was removed under vacuum; the residue was
washed with CH2Cl2, filtered and dried under vacuum.
Yield: 85%; m.p. 307-309 °C (decomp.); 1H NMR
(400.13 MHz, D2O): 3.14 (s, 6H, 1,3B-Me); 3.35 (s, 2H,
CH2) ppm. 13C NMR (100.62 MHz, D2O): 12.7 (CH2); 27.8
Yield: 70%; m.p. 223-226 °C (decomp.); 1H NMR
(400.13 MHz, D2O): 2.85 (s, 4H, B-CH2-S); 3.04 (s, 12H,
1,3B-Me); 3.08 (s, 12H, 1,3B(-ve)-Me); 3.29 (s, 4H, B-CH2-B)
ppm. 13C NMR (100.62 MHz, D2O): 27.8 (1,3B(-ve)-Me); 28.8
(1,3B-Me); 36.1 (CH2); 37.9 (CH2); 60.3 (C5 ); 83.1 (C5
(1,3B-Me); 80.6 (C5 ); 121.0 (CN); 153.9 (C2 ); 164.1 (C4,6
)
B
B
B
ppm. MS (FAB): m/z (%) = 168 (21) [M+ - CN], 194 (100)
[M+]. Anal. Calcd. for C8H8N3O3Na: C, 44.3; H, 3.7; N,
19.4. Found: C, 43.9; H, 4.1; N, 19.1%.
B
B(-
B(-
ve)); 153.2 (C2 ); 154.4 (C2B(-ve)); 164.2 (C4,6B); 171.6 (C4,6
B
ve)) ppm. MS (FAB): m/z (%) = 391 (63) [(M++Na)-
C7H8N2O3], 599 (100) [(M++Na)-C7H8N2O3], 727 (13)
[M++Na]. Anal. Calcd. for C28H32N8O12SNa2: C, 44.8; H,
4.3; N, 14.9. Found: C, 44.4; H, 4.1; N, 15.1%.
Sodium 5-[(1,3-dimethyl-2,4,6-trioxohexahydro-5-pyrimi-
dinyl)methyl]-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-4-
pyrimidinolate (4)
3.2 mmol (0.79 g) of 2 was dissolved in 15.0 mL of H2O,
and then 2.8 mmol (0.50 g) of sodium 1,3-dimethyl-2,6-
dioxo-1,2,3,6-tetrahydro-4-pyrimidinolate was added in one
portion to the aqueous solution which was stirred at r.t
overnight. The solvent was removed under vacuum; the
residue was washed with CHCl3, filtered and dried under
vacuum.
5-[(1,3-dimethyl-2,4,6-trioxohexahydro-5-pyrimidinyl)met-
hyl]-5-{[({5-[(1,3-dimethyl-2,4,6-trioxohexahydro-5-pyrimi-
dinyl)methyl]-1,3-dimethyl-2,4,6-trioxohexahydro-5-pyrim-
idinyl} methyl)sulfanyl]methyl}-1,3-dimethyl-2,4,6(1H,3H,
5H)-pyrimidinetrione (7)
To a clear aqueous solution of 1.8 mmol (1.35 g) of 6,
3.6 mmol (0.36 ml of 10 M HCl ) was added in one portion
followed by stirring at r.t for 30 min. The resulting
precipitate was filtered off, washed with distilled H2O and
dried under vacuum.
Yield: 80%; m.p. 237-240 °C (decomp.); 1H NMR
(400.13 MHz, D2O): 2.90 (t, 1H, C5 , J= 6.5 Hz); 2.98 (s,
B
6H, 1,3B-Me); 3.09 (s, 6H, 1,3B(-ve)-Me); 3.26 (d, 2H, CH2, J=
6.5 Hz) ppm. 13C NMR (100.62 MHz, D2O): 27.8 (1,3B(-ve)
-
Me); 28.8 (1,3B-Me); 40.0 (CH2); 55.2 (C5 ); 82.7 (C5B(-ve));
B
Yield: 83%; m.p. 129-132 °C; 1H NMR (400.13 MHz,
CDCl3): 2.80 (s, 4H, B-CH2-S); 3.23 (s, 12H, 1,3B-Me); 3.27
(s, 12H, 1,3B-Me); 3.59 (d, 4H, B-CH2-B, J= 6.7 Hz); 4.10 (t,
154.0 (C2 ); 164.4 (C4,6B); 173.2 (C4,6B(-ve)) ppm. MS (FAB):
B
m/z (%) = 153 (100) [NBA matrix], 169 (9) [M+-
2H, CB H, J= 6.7 Hz) ppm. 13C NMR (100.62 MHz, CDCl3):
5